Xiaoping Zhang (Hongmei Yang)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 55

Top Topics

Signaling Pathway

Histone Deacetylase

Renal Cell Carcinoma

Top Venues

Cell death & disease

Clinical and translational medicine

Cancer communications (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Zhihao Wei, Chenchen Liu, Jiaqian Liang, Xuan Zhou, Kaming Xue, Keshan Wang, Xiaoping Zhang
Characterization of Mitoribosomal Small Subunit unit genes related immune and pharmacogenomic landscapes in renal cell carcinoma. IUBMB life (2024)
Haibing Xiao, Yan Qu, Haolin Li, Yi Zhang, Mintian Fei, Chaozhao Liang, Hongmei Yang, Xiaoping Zhang
HIF-2α/LINC02609/APOL1-mediated lipid storage promotes endoplasmic reticulum homeostasis and regulates tumor progression in clear-cell renal cell carcinoma. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Daojia Miao, Jian Shi, Qingyang Lv, Diaoyi Tan, Chuanyi Zhao, Zhiyong Xiong, Xiaoping Zhang
NAT10-mediated ac 4 C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1. Cancer communications (London, England) 44 (3) (2024)
Daojia Miao, Jian Shi, Qingyang Lv, Diaoyi Tan, Chuanyi Zhao, Zhiyong Xiong, Xiaoping Zhang
NAT10-mediated ac 4 C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1. Cancer communications (London, England) 44 (3) (2024)
Chenchen Liu, Xiaoming Liu, Zhihao Wei, Zong Chang, Yaowei Bai, Pei Zeng, Qi Cao, Changjun Tie, Ziqiao Lei, Peng Sun, Huageng Liang, Qinchao Sun, Xiaoping Zhang
Amorphous Albumin Gadolinium-Based Nanoparticles for Ultrahigh-Resolution Magnetic Resonance Angiography. ACS applied materials & interfaces 16 (8) (2024)
Daojia Miao, Jian Shi, Qingyang Lv, Diaoyi Tan, Chuanyi Zhao, Zhiyong Xiong, Xiaoping Zhang
NAT10-mediated ac 4 C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1. Cancer communications (London, England) 44 (3) (2024)
Daojia Miao, Jian Shi, Qingyang Lv, Diaoyi Tan, Chuanyi Zhao, Zhiyong Xiong, Xiaoping Zhang
NAT10-mediated ac 4 C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1. Cancer communications (London, England) (2024)
Chenchen Liu, Xiaoming Liu, Zhihao Wei, Zong Chang, Yaowei Bai, Pei Zeng, Qi Cao, Changjun Tie, Ziqiao Lei, Peng Sun, Huageng Liang, Qinchao Sun, Xiaoping Zhang
Amorphous Albumin Gadolinium-Based Nanoparticles for Ultrahigh-Resolution Magnetic Resonance Angiography. ACS applied materials & interfaces 16 (8) (2024)
Daojia Miao, Jian Shi, Qingyang Lv, Diaoyi Tan, Chuanyi Zhao, Zhiyong Xiong, Xiaoping Zhang
NAT10-mediated ac 4 C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1. Cancer communications (London, England) 44 (3) (2024)
Chenchen Liu, Xiaoming Liu, Zhihao Wei, Zong Chang, Yaowei Bai, Pei Zeng, Qi Cao, Changjun Tie, Ziqiao Lei, Peng Sun, Huageng Liang, Qinchao Sun, Xiaoping Zhang
Amorphous Albumin Gadolinium-Based Nanoparticles for Ultrahigh-Resolution Magnetic Resonance Angiography. ACS applied materials & interfaces 16 (8) (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (7) (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (7) (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (7) (2024)
Zhihao Wei, Chenchen Liu, Jiaqian Liang, Xuan Zhou, Kaming Xue, Keshan Wang, Xiaoping Zhang
Characterization of Mitoribosomal Small Subunit unit genes related immune and pharmacogenomic landscapes in renal cell carcinoma. IUBMB life 76 (9) (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (7) (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (7) (2024)
Zirui Dong, Kaming Xue, Anushikha Verma, Jian Shi, Zhihao Wei, Xiaotian Xia, Keshan Wang, Xiaoping Zhang
Photothermal therapy: a novel potential treatment for prostate cancer. Biomaterials science (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (7) (2024)
Haibing Xiao, Yan Qu, Haolin Li, Yi Zhang, Mintian Fei, Chaozhao Liang, Hongmei Yang, Xiaoping Zhang
HIF-2α/LINC02609/APOL1-mediated lipid storage promotes endoplasmic reticulum homeostasis and regulates tumor progression in clear-cell renal cell carcinoma. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Chenchen Liu, Xiaoming Liu, Zhihao Wei, Zong Chang, Yaowei Bai, Pei Zeng, Qi Cao, Changjun Tie, Ziqiao Lei, Peng Sun, Huageng Liang, Qinchao Sun, Xiaoping Zhang
Amorphous Albumin Gadolinium-Based Nanoparticles for Ultrahigh-Resolution Magnetic Resonance Angiography. ACS applied materials & interfaces (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
Publisher Correction: N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (8) (2024)
Zirui Dong, Kaming Xue, Anushikha Verma, Jian Shi, Zhihao Wei, Xiaotian Xia, Keshan Wang, Xiaoping Zhang
Photothermal therapy: a novel potential treatment for prostate cancer. Biomaterials science 12 (10) (2024)
Zirui Dong, Kaming Xue, Anushikha Verma, Jian Shi, Zhihao Wei, Xiaotian Xia, Keshan Wang, Xiaoping Zhang
Photothermal therapy: a novel potential treatment for prostate cancer. Biomaterials science 12 (10) (2024)
Haibing Xiao, Yan Qu, Haolin Li, Yi Zhang, Mintian Fei, Chaozhao Liang, Hongmei Yang, Xiaoping Zhang
HIF-2α/LINC02609/APOL1-mediated lipid storage promotes endoplasmic reticulum homeostasis and regulates tumor progression in clear-cell renal cell carcinoma. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Zhihao Wei, Chenchen Liu, Jiaqian Liang, Xuan Zhou, Kaming Xue, Keshan Wang, Xiaoping Zhang
Characterization of Mitoribosomal Small Subunit unit genes related immune and pharmacogenomic landscapes in renal cell carcinoma. IUBMB life 76 (9) (2024)
Daojia Miao, Jian Shi, Qingyang Lv, Diaoyi Tan, Chuanyi Zhao, Zhiyong Xiong, Xiaoping Zhang
NAT10-mediated ac 4 C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1. Cancer communications (London, England) 44 (3) (2024)
Zirui Dong, Kaming Xue, Anushikha Verma, Jian Shi, Zhihao Wei, Xiaotian Xia, Keshan Wang, Xiaoping Zhang
Photothermal therapy: a novel potential treatment for prostate cancer. Biomaterials science 12 (10) (2024)
Chenchen Liu, Xiaoming Liu, Zhihao Wei, Zong Chang, Yaowei Bai, Pei Zeng, Qi Cao, Changjun Tie, Ziqiao Lei, Peng Sun, Huageng Liang, Qinchao Sun, Xiaoping Zhang
Amorphous Albumin Gadolinium-Based Nanoparticles for Ultrahigh-Resolution Magnetic Resonance Angiography. ACS applied materials & interfaces 16 (8) (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (7) (2024)
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Feiyi Lu, Hailong Ruan, Zhiyong Xiong, Xiaoping Zhang
Publisher Correction: N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Cell death & disease 15 (8) (2024)
Haibing Xiao, Yan Qu, Haolin Li, Yi Zhang, Mintian Fei, Chaozhao Liang, Hongmei Yang, Xiaoping Zhang
HIF-2α/LINC02609/APOL1-mediated lipid storage promotes endoplasmic reticulum homeostasis and regulates tumor progression in clear-cell renal cell carcinoma. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Jian Shi, Daojia Miao, Qingyang Lv, Keshan Wang, Qi Wang, Huageng Liang, Hongmei Yang, Zhiyong Xiong, Xiaoping Zhang
The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling. Cell death & disease 14 (8) (2023)
Daojia Miao, Qi Wang, Jian Shi, Qingyang Lv, Diaoyi Tan, Chuanyi Zhao, Zhiyong Xiong, Xiaoping Zhang
N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis-regulated Hippo pathway. Cancer communications (London, England) (2023)
Yuenan Liu, Kailei Chen, Yi Shou, Sen Li, Jun Wang, Qingyang Zhang, Ziwei Huang, Jiaju Xu, Mingfeng Li, Di Liu, Huageng Liang, Xiaoping Zhang, Xiaoping Zhang
circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma. Clinical and translational medicine 13 (12) (2023)
Yuenan Liu, Kailei Chen, Yi Shou, Sen Li, Jun Wang, Qingyang Zhang, Ziwei Huang, Jiaju Xu, Mingfeng Li, Di Liu, Huageng Liang, Xiaoping Zhang, Xiaoping Zhang
circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma. Clinical and translational medicine 13 (12) (2023)
Yuenan Liu, Kailei Chen, Yi Shou, Sen Li, Jun Wang, Qingyang Zhang, Ziwei Huang, Jiaju Xu, Mingfeng Li, Di Liu, Huageng Liang, Xiaoping Zhang, Xiaoping Zhang
circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma. Clinical and translational medicine 13 (12) (2023)
Keshan Wang, Fen Ma, Seiji Arai, Yun Wang, Andreas Varkaris, Larysa Poluben, Olga Voznesensky, Fang Xie, Xiaoping Zhang, Xin Yuan, Steven P Balk
WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth. Cancer research (2023)
Yi Shou, Changjie Yue, Qi Wang, Jingchong Liu, Jiaju Xu, Qi Miao, Di Liu, Hongmei Yang, Yuenan Liu, Xiaoping Zhang
circPTPN12 promotes the progression and sunitinib resistance of renal cancer via hnRNPM/IL-6/STAT3 pathway. Cell death & disease 14 (3) (2023)
Keshan Wang, Fen Ma, Seiji Arai, Yun Wang, Andreas Varkaris, Larysa Poluben, Olga Voznesensky, Fang Xie, Xiaoping Zhang, Xin Yuan, Steven P Balk
WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth. Cancer research (2023)
Yuenan Liu, Kailei Chen, Yi Shou, Sen Li, Jun Wang, Qingyang Zhang, Ziwei Huang, Jiaju Xu, Mingfeng Li, Di Liu, Huageng Liang, Xiaoping Zhang, Xiaoping Zhang
circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma. Clinical and translational medicine 13 (12) (2023)
Yuenan Liu, Kailei Chen, Yi Shou, Sen Li, Jun Wang, Qingyang Zhang, Ziwei Huang, Jiaju Xu, Mingfeng Li, Di Liu, Huageng Liang, Xiaoping Zhang, Xiaoping Zhang
circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma. Clinical and translational medicine 13 (12) (2023)
Yi Shou, Changjie Yue, Qi Wang, Jingchong Liu, Jiaju Xu, Qi Miao, Di Liu, Hongmei Yang, Yuenan Liu, Xiaoping Zhang
circPTPN12 promotes the progression and sunitinib resistance of renal cancer via hnRNPM/IL-6/STAT3 pathway. Cell death & disease 14 (3) (2023)
Keshan Wang, Fen Ma, Seiji Arai, Yun Wang, Andreas Varkaris, Larysa Poluben, Olga Voznesensky, Fang Xie, Xiaoping Zhang, Xin Yuan, Steven P Balk
WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth. Cancer research (2023)
Hailong Ruan, Sen Li, Lin Bao, Xiaoping Zhang
Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma. Oncogene (2022)
Jian Shi, Zhiyong Xiong, Keshan Wang, Changfei Yuan, Yu Huang, Wen Xiao, Xiangui Meng, Zhixian Chen, Qingyang Lv, Daojia Miao, Huageng Liang, Tianbo Xu, Kairu Xie, Hongmei Yang, Xiaoping Zhang
HIF2α promotes tumour growth in clear cell renal cell carcinoma by increasing the expression of NUDT1 to reduce oxidative stress. Clinical and translational medicine 11 (11) (2022)
Daojia Miao, Jian Shi, Zhiyong Xiong, Wen Xiao, Xiangui Meng, Qingyang Lv, Kairu Xie, Hongmei Yang, Xiaoping Zhang
As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner. Cancer cell international 22 (1) (2022)
Ning Xu, Wen Xiao, Xiangui Meng, Weiquan Li, Xuegang Wang, Xiaoping Zhang, Hongmei Yang
Up-regulation of SLC27A2 suppresses the proliferation and invasion of renal cancer by down-regulating CDK3-mediated EMT. Cell death discovery 8 (1) (2022)
Yuenan Liu, Jun Wang, Yi Shou, Wenjie Xu, Ziwei Huang, Jiaju Xu, Kailei Chen, Jingchong Liu, Di Liu, Huageng Liang, Hongmei Yang, Xiaoping Zhang
Restoring the epigenetically silenced lncRNA COL18A1-AS1 represses ccRCC progression by lipid browning via miR-1286/KLF12 axis. Cell death & disease 13 (7) (2022)
Shaohua Zeng, Bo Liu, Hu Hu, Jian Shi, Ping Qian, Xiaoping Zhang, Kexue Peng, Sixing Yang, Zheng Huang, Tiejun Pan
The Function Improved of the Newly Designed Magnetic-End Ureteric Stenting Retrieval Device: A Clinical Prospective Randomized and Control Trial in a Multicenter Study. Contrast media & molecular imaging 2022 (2022)
Weiquan Li, Xiangui Meng, Hongwei Yuan, Wen Xiao, Xiaoping Zhang
M2-polarization-related CNTNAP1 gene might be a novel immunotherapeutic target and biomarker for clear cell renal cell carcinoma. IUBMB life 74 (5) (2022)
Xiangui Meng, Hongwei Yuan, Weiquan Li, Zhiyong Xiong, Wei Dong, Wen Xiao, Xiaoping Zhang
Solute carrier family 16 member 5 downregulation and its methylation might serve as a prognostic indicator of prostate cancer. IUBMB life 73 (11) (2021)
Qi Wang, Jiaju Xu, Zhiyong Xiong, Tianbo Xu, Jingchong Liu, Yuenan Liu, Jiaping Chen, Jian Shi, Yi Shou, Changjie Yue, Di Liu, Huageng Liang, Hongmei Yang, Xiong Yang, Xiaoping Zhang
CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway. Journal of translational medicine 19 (1) (2021)
Zhiyong Xiong, Wei Xiong, Wen Xiao, Changfei Yuan, Jian Shi, Yu Huang, Cheng Wang, Xiangui Meng, Zhixian Chen, Hongmei Yang, Ke Chen, Xiaoping Zhang
NNT-induced tumor cell "slimming" reverses the pro-carcinogenesis effect of HIF2a in tumors. Clinical and translational medicine 11 (1) (2021)
Wen Xiao, Ke Chen, Xiaoping Zhang
Pivotal biomarker expression and drug screening in advanced ccRCC. Clinical and translational medicine 10 (2) (2020)
Hailong Ruan, Sen Li, Lin Bao, Xiaoping Zhang
Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma. Oncogene 39 (38) (2020)